StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a research note issued to investors on Tuesday. The firm issued a sell rating on the stock.
Separately, Craig Hallum raised shares of Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.
Check Out Our Latest Report on STRM
Streamline Health Solutions Trading Down 5.8 %
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last released its earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). The firm had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.
Streamline Health Solutions Company Profile
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Further Reading
- Five stocks we like better than Streamline Health Solutions
- 10 Best Airline Stocks to Buy
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- What Are Dividends? Buy the Best Dividend Stocks
- 3 Penny Stocks Ready to Break Out in 2025
- What Investors Need to Know to Beat the Market
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.